The main talking points at COT’s July meeting related to the toxicity of substances within the infant diet and in other vulnerable groups.  The following papers were discussed:

  • A pilot double-blind placebo crossover study of aspartame in subjects who have reported symptoms in the past (TOX/2013/26). [Paper not currently available on the website.]
  • A possible blind placebo-controlled parallel trial of soy phytoestrogens in patients with compensated hypogonadism (TOX/2013/27).
  • Second draft statement on endosulfan isomers, pentachlorobenzene and chlordecone, in relation to the infant diet (TOX/2013/28).
  • Fourth draft statement on the potential risks from lead in the infant diet (TOX/2013/29).
  • Fourth draft statement on the potential risks from high levels of vitamin A in the infant diet (TOX/2013/30).
  • A report concerning potassium salt replacers in vulnerable groups, particularly relating to adverse effects on the kidney (TOX/2013/31).

UK Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment. COT agenda and papers: 2 July 2013.

http://cot.food.gov.uk/cotmtgs/cotmeets/cotmeets2013/cotmeetjuly13/cotagepap2july13

 

 

The above item was taken from the August 2013 issue of Toxicology and Regulatory News which is sent automatically to members of bibra (click here for more details).